Clinical application of radiofrequency ablation assisted hepatectomy to primary hepatocellural carcinoma

Qiu Hua,Xiang Deng,Wan Ren-hua,Shi Jun,Shan Ren-feng
DOI: https://doi.org/10.3969/j.issn.1005-8982.2018.10.021
2018-01-01
Abstract:Objective To explore the safety and clinical efficacy of radiofrequency ablation assisted hepatectomy in the treatment of primary hepatocellural carcinoma. Methods The clinical data of 52 hepatocellular carcinoma patients who accepted surgical resection in our hospital from June 2013 to December 2015 were retrospectively analyzed. Among them 26 patients in the observation group underwent radiofrequency ablation and surgical resection, while 26 patients in the control group underwent only surgical procedures. The operation time, situation of occlusion of hepatic blood inflow, intraoperative bleeding, complete resection rate of tumor, postoperative complications and the postoperative cancer recurrence rate in 3, 6 and 12 months after operation were compared. Results The two groups of patients underwent R0 resection successfully. There was no significant difference in the operation time between the two groups (P > 0.05). But the intraoperative bleeding, the frequency of occlusion of hepatic blood inflow and the incidences of postoperative complications in the observation group were significantly lower than those of the control group (P < 0.05). There was no recurrence during 3, 6 and 12 months after operation in each group. Conclusions Compared with the traditional hepatectomy, surgical resection combined radiofrequency ablation can effectively decrease intraoperative bleeding, frequency of occlusion of hepatic blood inflow and incidences of postoperative complications. It is a safe and reliable therapeutic regimen for primary hepatocellular carcinoma.
What problem does this paper attempt to address?